Cite
APA Citation
Jaderberg, M., Cedres, S., Paz-Ares, L., Serres, X., Ricordel, C., Isambert, N., Aix, S. P., Levitsky, V., Kuryk, L., Moller, A., & Vetrhus, S. (n.d.). 361 A randomised open-label phase I/II study adding ONCOS-102 to pemetrexed/cisplatin in patients with unresectable malignant pleural mesothelioma – 12 month analysis of biomarkers and clinical outcomes. Journal for immunotherapy of cancer, 8, A220–A221. http://access.bl.uk/ark:/81055/vdc_100144713826.0x000001